Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Boj proti bakterijski odpornosti : ali so bakterijske topoizomeraze tipa II še zanimive tarče?
Authors:ID Zorman, Maša (Author)
ID Minovski, Nikola (Author)
ID Anderluh, Marko (Author)
ID Gobec, Stanislav (Author)
ID Hrast, Martina (Author)
Files:.pdf PDF - Presentation file, download (6,35 MB)
MD5: 713BC6AB67727047AFFD9EE666DA450B
 
Language:Slovenian
Typology:1.02 - Review Article
Organization:Logo SFD - Slovenian Pharmaceutical Society
Abstract:Topoizomeraze tipa II so pomembne tarče za proti - bakterijsko terapijo. Prvi zaviralci topoizomeraz tipa II, kinoloni in aminokumarini, so se na trgu pojavili že pred desetletji, vendar njihova uporabnost postopoma upada zaradi nizke učinkovitosti, neželenih učinkov in pojava bakterijske rezistence. Za premagovanje odpornosti in ohranjanje topoizomeraz kot zanimivih tarč, so ključne inovacije na tem področju – izboljšanje dosedanjih razredov učinkovin in odkrivanje novih tipov zaviralcev. V članku so predstavljeni različni razredi zaviralcev bakterijskih topoizomeraz, njihove prednosti in slabosti ter obeti za prihodnost.
Keywords:aminokumarini, novi zaviralci bakterijskih topoizomeraz, kinoloni, protibakterijska terapija, zaviralci topoizomeraze tipa II
Publication status:Published
Publication version:Version of Record
Publication date:01.01.2025
Year of publishing:2025
Number of pages:str. 10-21
Numbering:Letn. 76, Št. 1
PID:20.500.12556/DiRROS-22880 New window
UDC:615.015.8
ISSN on article:0014-8229
COBISS.SI-ID:230959875 New window
Publication date in DiRROS:08.07.2025
Views:317
Downloads:129
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Farmacevtski vestnik : strokovno glasilo slovenske farmacije
Shortened title:Farm. vestn.
Publisher:Slovensko farmacevtsko društvo
ISSN:0014-8229
COBISS.SI-ID:3105794 New window

Licences

License:CC BY-NC 4.0, Creative Commons Attribution-NonCommercial 4.0 International
Link:http://creativecommons.org/licenses/by-nc/4.0/
Description:A creative commons license that bans commercial use, but the users don’t have to license their derivative works on the same terms.

Secondary language

Language:English
Title:The fight against bacterial resistance : are bacterial type II topoisomerases still interesting targets?
Abstract:Type II topoisomerases are important targets for antibacterial therapy. The first inhibitors of type II topoisomerases, quinolones and aminocoumarins, emerged more than half a century ago, but their use is now in slow decline due to toxic side effects, low effectiveness and emergence of bacterial resistance. Innovations in this field – improvement of already existing classes of antibacterials and discovery of novel classes of compounds, are essential for overcoming resistance and maintaining topoisomerases as viable targets. In this paper, we present various classes of bacterial topoisomerase inhibitors, their advantages and shortcomings, as well as future perspectives.


Collection

This document is a part of these collections:
  1. Farmacevtski vestnik

Back